These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 15925772

  • 1. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
    Matsumura A, Isobe T, Anno I, Takano S, Kawamura H.
    J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
    [Abstract] [Full Text] [Related]

  • 2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 3. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX.
    Chin Med J (Engl); 2009 Jan 05; 122(1):39-43. PubMed ID: 19187615
    [Abstract] [Full Text] [Related]

  • 4. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
    Tong ZY, Toshiaki Y, Wang YJ.
    Chin Med J (Engl); 2005 Aug 05; 118(15):1251-7. PubMed ID: 16117877
    [Abstract] [Full Text] [Related]

  • 5. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF, Wang XY, Gong CG, Liu F, Wang RW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 05; 28(8):1342-4. PubMed ID: 18753055
    [Abstract] [Full Text] [Related]

  • 6. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
    Yu HW, Tanabe S, Yamaki T, Harada K, Hashi K.
    No Shinkei Geka; 2000 Dec 05; 28(12):1063-9. PubMed ID: 11193526
    [Abstract] [Full Text] [Related]

  • 7. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N, Morales H, Modrego PJ, Pina MA.
    Acad Radiol; 2006 Jun 05; 13(6):728-37. PubMed ID: 16679275
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C, Hattingen E, Pilatus U, Franz K, Schänzer A, Lanfermann H, Seifert V, Gasser T.
    Neurosurgery; 2009 Nov 05; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [Abstract] [Full Text] [Related]

  • 9. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK, Iplikcioglu AC, Dincer A, Arslan M, Sav A.
    Eur J Radiol; 2006 Oct 05; 60(1):48-55. PubMed ID: 16844335
    [Abstract] [Full Text] [Related]

  • 10. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Tong Z, Yamaki T, Harada K, Houkin K.
    Magn Reson Imaging; 2004 Sep 05; 22(7):1017-24. PubMed ID: 15288143
    [Abstract] [Full Text] [Related]

  • 11. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
    Toyooka M, Kimura H, Uematsu H, Kawamura Y, Takeuchi H, Itoh H.
    Clin Imaging; 2008 Sep 05; 32(4):251-8. PubMed ID: 18603178
    [Abstract] [Full Text] [Related]

  • 12. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Tong Z, Yamaki T, Harada K, Houkin K.
    Magn Reson Imaging; 2004 Jun 05; 22(5):735-42. PubMed ID: 15172069
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M, Jancalek R, Vanicek J, Skoch A, Mechl M.
    Clin Neurol Neurosurg; 2013 Feb 05; 115(2):146-53. PubMed ID: 23237636
    [Abstract] [Full Text] [Related]

  • 15. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.
    Neuroimage; 2004 Oct 05; 23(2):454-61. PubMed ID: 15488395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
    Stadlbauer A, Nimsky C, Buslei R, Pinker K, Gruber S, Hammen T, Buchfelder M, Ganslandt O.
    Invest Radiol; 2007 Apr 05; 42(4):218-23. PubMed ID: 17351427
    [Abstract] [Full Text] [Related]

  • 18. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.
    Invest Radiol; 2013 May 05; 48(5):295-301. PubMed ID: 23296081
    [Abstract] [Full Text] [Related]

  • 19. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS, Li CF, Liu H, Zhen JH, Feng DC.
    Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):151-8. PubMed ID: 17289287
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A, Murtha A, Abdulkarim B, Mehta V, Wheatley M, Murray B, Riauka T, Hanson J, Fulton D, McEwan A, Roa W.
    Clin Invest Med; 2006 Oct 01; 29(5):301-11. PubMed ID: 17144440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.